{"id":536,"date":"2008-01-25T18:16:00","date_gmt":"2008-01-25T18:16:00","guid":{"rendered":"http:\/\/staging.grindeks.eu\/?p=536"},"modified":"2022-06-27T18:17:55","modified_gmt":"2022-06-27T18:17:55","slug":"farmacijas-nozares-eksperti-pieaugs-terini-medikamentiem","status":"publish","type":"post","link":"https:\/\/grindeks.com\/lv\/farmacijas-nozares-eksperti-pieaugs-terini-medikamentiem\/","title":{"rendered":"Farm\u0101cijas nozares eksperti: Pieaugs t\u0113ri\u0146i medikamentiem"},"content":{"rendered":"\n

2007. gads farm\u0101cijas nozarei bijis veiksm\u012bgs. Farm\u0101cijas komp\u0101nijas k\u0101pin\u0101ja pe\u013c\u0146as r\u0101d\u012bt\u0101jus, z\u0101\u013cu p\u0101rdo\u0161anas apjomus. Saska\u0146\u0101 ar “IMS Health” sniegto inform\u0101ciju 2007. gada 11 m\u0113ne\u0161os kopum\u0101 Latvij\u0101 aptiek\u0101s un slimn\u012bc\u0101s medikamenti realiz\u0113ti par 166 055789 Ls, kas ir 24 % vair\u0101k nek\u0101 \u0161\u012b pa\u0161a perioda 2006. gad\u0101. Lai nostiprin\u0101tu savas poz\u012bcijas tirg\u016b uz\u0146\u0113mumi akt\u012bvi, mekl\u0113ja jaunas iesp\u0113jas savas produkcijas realiz\u0113\u0161anai, tirg\u016b, ien\u0101ca jaun\u0101s paaudzes medikamenti. \u0160\u012b gada s\u0101kum\u0101 da\u017e\u0101du nozaru eksperti steidz izteikt prognozes par gaid\u0101majiem notikumiem 2008. gad\u0101. Ar\u012b Nozare.lv v\u0113rs\u0101s pie liel\u0101kajiem Latvijas farm\u0101cijas uz\u0146\u0113mumu p\u0101rst\u0101vjiem – AS \u201eGrindeks” un AS \u201eOlainfarm”, lai uzzin\u0101tu ar vi\u0146u prognozes.<\/p>\n\n\n\n

K\u0101di b\u016bs medikamentu ra\u017eot\u0101ju un tirgot\u0101ju darb\u012bbas izaugsmes tempi?<\/strong><\/p>\n\n\n\n

AS Grindeks valdes priek\u0161s\u0113d\u0113t\u0101js J\u0101nis Romanovskis (J. R.):<\/strong> \u2013 2008. gad\u0101 nozar\u0113 saglab\u0101sies pag\u0101ju\u0161\u0101 gada izaugsmes tempi.<\/p>\n\n\n\n

AS \u201cOlainFarm\u201d komercijas un m\u0101rketinga departamenta direktors Jurijs Kaplinovs<\/strong> (J. K.) <\/strong>\u2013 Medikamentu ra\u017eot\u0101ju un tirgot\u0101ju darb\u012bbas izaugsmes tempi b\u016bs vid\u0113ji augsti. \u0145emot v\u0113r\u0101 komp\u0101niju izaugsmes dinamiku, infl\u0101cijas r\u0101d\u012bt\u0101jus, energoresursu izmaksu un darbinieku atalgojuma pieaugumu, varam sagaid\u012bt vid\u0113j\u0101 izaugsmes tempa pieaugumu par 20 \u2013 25% gad\u0101.<\/p>\n\n\n\n

Vai iedz\u012bvot\u0101ju t\u0113ri\u0146i z\u0101l\u0113m pieaugs?<\/strong><\/p>\n\n\n\n

J.R<\/strong> \u2013 Prognoz\u0113jam, ka iedz\u012bvot\u0101ju t\u0113ri\u0146i z\u0101l\u0113m pieaugs, jo, pirmk\u0101rt, cilv\u0113kiem kopum\u0101 b\u016bs vair\u0101k naudas, otrk\u0101rt, pieaugs z\u0101\u013cu cenas.<\/p>\n\n\n\n

J.K.<\/strong> \u2013 Cilv\u0113ku t\u0113ri\u0146i z\u0101l\u0113m, t\u0101pat k\u0101 p\u0101rtikas produktiem, citiem produktiem un pakalpojumiem, pieaugs. Glu\u017ei vienk\u0101r\u0161i \u2013 augstas infl\u0101cijas apst\u0101k\u013cos ar\u012b farm\u0101cijas uz\u0146\u0113mumi ir spiesti celt savas produkcijas cenas, lai kompens\u0113tu pieaugo\u0161os darb\u012bbas izdevumus. Varam ar\u012b nov\u0113rot, ka pieaug rindas pie \u0123imenes \u0101rstiem, palielin\u0101s pakalpojumu cenas pie speci\u0101listiem \u2013 \u0101rsta pieejam\u012bba samazin\u0101s, kas rezult\u0113jas smagu, ielaistu slim\u012bbu pieaugum\u0101. Savuk\u0101rt to \u0101rst\u0113\u0161ana prasa iev\u0113rojami liel\u0101kus t\u0113ri\u0146us gan pacientam, gan valstij, jo ar\u012b medikamenti ir j\u0101lieto vair\u0101k, d\u0101rg\u0101ki un ilg\u0101ku laiku.<\/p>\n\n\n\n

K\u0101d\u0101s jom\u0101s var\u0113tu gaid\u012bt jaunu z\u0101\u013cu ien\u0101k\u0161anu tirg\u016b?<\/strong><\/p>\n\n\n\n

J.R.<\/strong> \u2013 AS Grindeks turpin\u0101s strat\u0113\u0123iski izstr\u0101d\u0101t medikamentus galvenaj\u0101s terapeitiskaj\u0101s grup\u0101s \u2013 sirds un asinsvadu slim\u012bb\u0101m, onkolo\u0123ij\u0101, centr\u0101lo nervu sist\u0113mu ietekm\u0113jo\u0161\u0101m slim\u012bb\u0101m.<\/p>\n\n\n\n

J.K.<\/strong> \u2013 Visi Latvijas medikamentu ra\u017eot\u0101ji patst\u0101v\u012bgi vai sadarb\u012bb\u0101 ar \u0101rvalstu ra\u017eot\u0101jiem str\u0101d\u0101 pie produktu portfe\u013ca papla\u0161in\u0101\u0161anas. Ar\u012b \u201cOlainFarm\u201d sadarb\u012bb\u0101 ar Latvijas Organisk\u0101s sint\u0113zes instit\u016btu izstr\u0101d\u0101 jaunus produktus, kuriem pa\u0161laik jau tiek att\u012bst\u012btas ra\u017eo\u0161anas tehnolo\u0123ijas un veikti kl\u012bniskie p\u0113t\u012bjumi. Parasti jaunu produktu izveide un ievie\u0161ana tirg\u016b vid\u0113ji ilgst 5 \u2013 7 gadus. Uzlabotas z\u0101\u013cu formas no viet\u0113jiem ra\u017eot\u0101jiem var\u0113tu ien\u0101kt tirg\u016b t\u0101d\u0101s jom\u0101s k\u0101 kardiolo\u0123ija un neirolo\u0123ija. Uzskatu, ka nek\u0101dus sensacion\u0101lus p\u0101rsteigumus tirg\u016b nepied\u0101v\u0101s ar\u012b \u0101rvalstu ra\u017eot\u0101ji, dr\u012bz\u0101k tie var\u0113tu b\u016bt uzlaboti tradicion\u0101lie l\u012bdzek\u013ci kardiolo\u0123ij\u0101.<\/p>\n\n\n\n

K\u0101 v\u0113rt\u0113jat medic\u012bnas zin\u0101tnes perspekt\u012bvas?<\/strong><\/p>\n\n\n\n

J.<\/strong>R.<\/strong> \u2013 Perspekt\u012bvas ir \u013coti labas, jo \u0161\u012b ir viena no t\u0101m jom\u0101m, kam ir milz\u012bgs zin\u0101tnisko atkl\u0101jumu potenci\u0101ls un praktiskais pielietojums n\u0101kotn\u0113.<\/p>\n\n\n\n

J.K.<\/strong> \u2013 Latvij\u0101 v\u0113sturiski jau no 19. gadsimta, neatkar\u012bgi no valsts iek\u0101rtas, ir sp\u0113c\u012bgi att\u012bst\u012bta medic\u012bna, \u0137\u012bmija un farm\u0101cija. \u0136\u012bmijas un farm\u0101cijas att\u012bst\u012bbas perspekt\u012bvas p\u0113c iest\u0101\u0161an\u0101s Eiropas Savien\u012bb\u0101 ir \u013coti cer\u012bgas. Latvijas farm\u0101cijas uz\u0146\u0113mumi ir Eiropas Savien\u012bbas standartu l\u012bmen\u012b. Ja skat\u0101mies glob\u0101l\u0101 perspekt\u012bv\u0101, iesp\u0113jams, pat ne p\u0101r\u0101k t\u0101l\u0101 n\u0101kotn\u0113 iev\u0113rojami pieaugs g\u0113nu in\u017eenierijas loma, kas pat var\u0113tu ie\u0146emt tradicion\u0101l\u0101s farm\u0101cijas vietu. Iesp\u0113jams, ka ar\u012b Latvijas zin\u0101tnieki \u0161aj\u0101 jom\u0101 dos savu artavu.<\/p>\n\n\n\n

Ar k\u0101d\u0101m gr\u016bt\u012bb\u0101m b\u016bs j\u0101saskaras 2008.g?<\/strong><\/p>\n\n\n\n

J.R.<\/strong> \u2013 Pirmk\u0101rt, saimniecisk\u0101s darb\u012bbas pl\u0101no\u0161ana, jo neprognoz\u0113jami un \u0101tri pieaug izejvielu un energoresursu cenas. Otrk\u0101rt, atalgojuma pieaugums, kas palielina rot\u0101ciju darba tirg\u016b un sad\u0101rdzina jauna darbasp\u0113ka piesaist\u012b\u0161anu. Tre\u0161k\u0101rt, jaunas z\u0101\u013cu tirgu regul\u0113jo\u0161\u0101s pras\u012bbas, kuru iev\u0113ro\u0161ana prasa papildu laiku un l\u012bdzek\u013cus.<\/p>\n\n\n\n

J.K.<\/strong> \u2013 Glob\u0101la rakstura gr\u016bt\u012bbas: energoresursu cenu pieaugums, stingr\u0101ka banku kredit\u0113\u0161anas politika, \u201cdrudzis\u201d fondu tirgos. Farm\u0101cijas nozar\u0113 Latvij\u0101 arvien spilgt\u0101k izpaud\u012bsies jaunu, kvalific\u0113tu darbinieku un vid\u0113j\u0101 l\u012bme\u0146a speci\u0101listu tr\u016bkums.<\/p>\n\n\n\n

K\u0101 politiskie un ekonomiskie procesi var\u0113tu ietekm\u0113t farm\u0101cijas nozares att\u012bst\u012bbu?<\/strong><\/p>\n\n\n\n

J.R.<\/strong> \u2013 Ekonomiskie procesi atst\u0101j moment\u0101nu ietekmi, savuk\u0101rt, politiskie l\u0113mumi nozares att\u012bst\u012bbu ietekm\u0113 ilgtermi\u0146\u0101, piem\u0113ram, at\u0161\u0137ir\u012bbas z\u0101\u013cu re\u0123istr\u0101cijas, ra\u017eo\u0161anas u.c. regul\u0113jo\u0161aj\u0101s pras\u012bb\u0101s ES un cit\u0101s valst\u012bs prasa uz\u0146\u0113muma elast\u012bbu un sp\u0113ju piel\u0101goties katras attiec\u012bg\u0101s valsts likumdo\u0161anai.<\/p>\n\n\n\n

Rita Kozlova
LETA-EPI<\/p>\n","protected":false},"excerpt":{"rendered":"

2007. gads farm\u0101cijas nozarei bijis veiksm\u012bgs. Farm\u0101cijas komp\u0101nijas k\u0101pin\u0101ja pe\u013c\u0146as r\u0101d\u012bt\u0101jus, z\u0101\u013cu p\u0101rdo\u0161anas apjomus. Saska\u0146\u0101 ar “IMS Health” sniegto inform\u0101ciju 2007. gada 11 m\u0113ne\u0161os kopum\u0101…<\/p>\n","protected":false},"author":3,"featured_media":6601,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[2],"tags":[],"class_list":["post-536","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-jaunums"],"acf":[],"_links":{"self":[{"href":"https:\/\/grindeks.com\/lv\/wp-json\/wp\/v2\/posts\/536","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/grindeks.com\/lv\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/grindeks.com\/lv\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/grindeks.com\/lv\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/grindeks.com\/lv\/wp-json\/wp\/v2\/comments?post=536"}],"version-history":[{"count":0,"href":"https:\/\/grindeks.com\/lv\/wp-json\/wp\/v2\/posts\/536\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/grindeks.com\/lv\/wp-json\/wp\/v2\/media\/6601"}],"wp:attachment":[{"href":"https:\/\/grindeks.com\/lv\/wp-json\/wp\/v2\/media?parent=536"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/grindeks.com\/lv\/wp-json\/wp\/v2\/categories?post=536"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/grindeks.com\/lv\/wp-json\/wp\/v2\/tags?post=536"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}